Product sales
Our complementary healthcare businesses address the changing needs of patients and societies worldwide. With innovative pharmaceuticals at the core, we are also a global leader in generics, vaccines and consumer health products.
We believe this targeted portfolio best meets the challenges and opportunities in a dynamically changing healthcare environment.
Read more about the sales of our products.
| View by: |
| Product | Full Year 2008 Product Sales | Indication / Therapeutic Area | |
|---|---|---|---|
| USD m | variance in USD | ||
 |
5740 | 15% | Hypertension / Cardiovascular Metabolism and Endocrinology |
|
|||
 |
3670 | 20% | Chronic myeloid leukemia / Oncology Hematology |
|
|||
 |
1382 | 7% | Cancer complications / Oncology Hematology |
|
|||
 |
1129 | 20% | Breast cancer / Oncology Hematology |
|
|||
 |
1123 | 9% | Acromegaly / Oncology Hematology |
|
|||
 |
956 | 1% | Transplantation / Transplantation |
|
|||
 |
886 | 125% | Age-related macular degeneration / Ophthalmics |
|
|||
 |
815 | 29% | Alzheimer's disease / Central Nervous System |
|
|||
 |
814 | 9% | Inflammation / pain / Rheumatology Bone and Hormone Replacement Therapy |
|
|||
 |
645 | -3% | Cholesterol reduction / Cardiovascular Metabolism and Endocrinology |
|
|||
 |
531 | 49% | Iron chelator / Oncology Hematology |
|
|||
 |
502 | 20% | Parkinson's disease / Central Nervous System |
|
|||
 |
451 | 9% | Epilepsy / Central Nervous System |
|
|||
 |
440 | 17% | Attention deficit disorder / Central Nervous System |
|
|||
 |
406 | 294% | Hypertension / Cardiovascular Metabolism and Endocrinology |
|
|||
 |
387 | 7% | Asthma / Respiratory |
|
|||
 |
386 | -48% | Hypertension / Cardiovascular Metabolism and Endocrinology |
|
|||
 |
332 | -52% | Epilepsy / Central Nervous System |
|
|||
 |
295 | 8% | Cystic fibrosis / Respiratory |
|
|||
 |
290 | 50% | Transplantation / Transplantation |
